- Home
- Life Sciences
- Pharmaceutical
- Therapy
- Therapy Analysis & Statistics, February 2013 (p5)
Talk to Alison
00 1 718 618 48 97
Search inside this page
Top countries
- United States (1 208)
- World (3 310)
- Canada (105)
- Japan (366)
- China (85)
-
- Australia (45)
- India (57)
- Denmark (22)
- North America (25)
- Israel (16)
- Italy (298)
- United Kingdom (320)
- Chad (2)
- Philippines (16)
- South Korea (21)
- Taiwan (14)
- Austria (1)
- Germany (313)
- Ireland (7)
- Netherlands (12)
Publication dates
Publishers
- Global Data (901)
- Global Markets Direct (2 890)
- MarketLine (168)
- Bioseeker (6)
- Currentpartnering (130)
-
- Axis Research Mind (1)
- GBI Research (79)
- ICD Research (15)
- Infiniti Research Limited (6)
- RNCOS (9)
- Transparency Market Research (3)
- Life Science Analytics (LSA) (738)
- Timely Data Resources Inc. (63)
- Frost & Sullivan (60)
- Datamonitor (58)
- Global Industry Analyst (23)
- La Merie Publishing (18)
- BCC Research (13)
- SCRIP Insights (12)
- CHI Insight Pharma Reports (10)
- Visiongain (10)
- Arrowhead (7)
- Business Review (7)
- Venture Planning Group (7)
- Asia Market Information & Development Company (6)
- Firstword Pharma (6)
- Greystone Research Associates (6)
- Koncept Analytics (6)
- MarketsandMarkets (6)
- Aruvian's R'search (5)
- Kalorama Information (5)
- Ibisworld (4)
- TriMark Publications (4)
- World Market Intelligence Ltd (3)
- Canadean Ltd (2)
- Urch Publishing (2)
- BioPharm Reports (1)
- CCM International Limited (1)
- Espicom Business Intelligence (1)
- Global Industry Analysts (1)
- IPEXL (1)
- Pharmavision (1)
- Renub Research (1)
- Research In China (1)
- Sociable Pharma (1)
- VacZine Analytics Group Of Assay Advantage Ltd (1)
All regions
-
- Austria (1)
- Belgium (3)
- Denmark (22)
- Estonia (1)
- Finland (8)
- France (293)
- Germany (313)
- Greece (14)
- Hungary (1)
- Ireland (7)
- Italy (298)
- Netherlands (12)
- Norway (5)
- Poland (10)
- Portugal (1)
- Romania (3)
- Russian Federation (20)
- Serbia and Montenegro (2)
- Spain (295)
- Sweden (24)
- Switzerland (7)
- Ukraine (1)
- United Kingdom (320)
-
- Australia (45)
- Austria (1)
- Belgium (3)
- Canada (105)
- Chile (4)
- Denmark (22)
- Estonia (1)
- Finland (8)
- France (293)
- Germany (313)
- Greece (14)
- Hungary (1)
- Ireland (7)
- Israel (16)
- Italy (298)
- Japan (366)
- Mexico (24)
- Netherlands (12)
- New Zealand (1)
- Norway (5)
- Poland (10)
- Portugal (1)
- South Korea (21)
- Spain (295)
- Sweden (24)
- Switzerland (7)
- Turkey (1)
- United Kingdom (320)
- United States (1 208)
data types
Free Market Research Guides to Download
Therapy Analysis & Statistics, February 2013 (p5)
You might be interested in: therapeutics, biotherapeutics, therapy review, more »
» Purchase Premium Reports
121-150 of about 5 300 reports
World Therapy: Uveitis - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Uveitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...
- Industries : Therapy
- Countries : World
World Therapy: Oral Mucositis - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Oral Mucositis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Therapy
- Countries : World
World Therapy: Scar - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Scar, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the ...
- Industries : Therapy
- Countries : World
World Therapy: Fibromyalgia - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Fibromyalgia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Therapy
- Countries : World, Japan, United States
High Triglyceridemia - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
High Triglyceridemia - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'High Triglyceridemia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This ...
- Industries : Therapy
- Countries : United States
World Drug and Medication: Male Hypogonadism - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Male Hypogonadism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Therapy
- Countries : World
World Therapy: Genital Herpes - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Genital Herpes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Therapy
- Countries : World
Eczema - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Eczema - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Eczema - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...
- Industries : Therapy
- Countries : China, World
World Therapy: Growth Disorders - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Growth Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Therapy
- Countries : World
Therapy in China: Dysmenorrhea - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
- Industries : Therapy
- Countries : China, World, United States
World Therapy: Venous Thromboembolism - Pipeline Review, H1 2012
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Venous Thromboembolism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
- Industries : Therapy
- Countries : World
Pyelonephritis - Pipeline Review, H1 2013
- $ 2 000
- Industry report
- February 2013
- by Global Markets Direct
Pyelonephritis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Pyelonephritis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...
- Industries : Therapy
- Countries : World
Radiation Therapy in Oncology Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
This drug pipeline update is structured around radiolabeled drugs, radiosensitizers and radioprotective compounds. There are today 321 companies plus partners developing 337 radiation therapy drugs in ...
- Industries : Therapy
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2013
- $ 2 249
- Industry report
- April 2013
- by Bioseeker
Nucleic acid therapies in oncology includes: Gene Therapy, DNA vaccine, Other DNA technologies, RNA Interference (RNAi), Small interfering RNA (siRNA), Antisense RNA and Ribozymes. There are today 221 ...
- Industries : Therapy
Cellular Therapy in Oncology Drug Pipeline Update 2013
- $ 1 499
- Industry report
- April 2013
- by Bioseeker
There are today 72 companies plus partners developing 59 cellular therapy drugs in 127 developmental projects in cancer. In addition, there are 5 suspended drugs and the accumulated number of ceased drugs ...
- Industries : Therapy
Cytokine Therapy in Oncology Drug Pipeline Update 2013
- $ 1 499
- Industry report
- April 2013
- by Bioseeker
There are today 82 companies plus partners developing 105 cytokine drugs in 206 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs ove ...
- Industries : Therapy
Personalized Medicine Market Analysis
- $ 1 200
- Industry report
- May 2013
- by RNCOS
Advancements in the field of genomics have created ample opportunities for personalized medicines to emerge in the healthcare industry. Personalized medicine represents an interface of therapeutics and ...
- Industries : Therapy
ImmunoCellular Therapeutics, Ltd. (IMUC) - Product Pipeline Analysis, 2013 Update
- $ 750
- Company report
- May 2013
- by Global Data
Summary ImmunoCellular Therapeutics, Ltd. (IMCU) is a clinical-stage biotechnology company. It develops immune-based therapies for the treatment of various cancers. The product pipeline of the company ...
- Industries : Therapy
- Countries : United States
Biolex Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Therapy
TomoTherapy Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Therapy
Cardium Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Therapy
Northwest Biotherapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Therapy
Acorda Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Therapy
Fate Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Therapy
Point Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Therapy
Forma Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Therapy
Silence Therapeutics plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Therapy
United Therapeutics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Therapy
Cornerstone Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Therapy
Talecris Biotherapeutics Holdings Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- $ 350
- Company report
- March 2013
- by MarketLine
Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...
- Industries : Therapy
» Download Public Reports
About 1 000 reports
Kelly, Geren and Searcy - Company Report for Year 2013
- Company report
- January 2013
- 5 pages
- by Corporation
Partnership Ltd. - Company Report For Year 2012
December 2012Company Report: Hydrotherapy For Year 2013
March 2013U.s. Therapy Business Brief Analysis
January 2013» Read our Company Profiles
84 CompaniesNovartis Inc.
SwitzerlandGlaxoSmithKline P.L.C.
United StatesPfizer Inc.
United StatesGlaxoSmithKline PLC
United KingdomSanofi-Aventis Senegal
SenegalReportlinker.com © Copyright 2013. All rights reserved.
